Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in United StatesA Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
- Where
- Boston
- People
- 30,000
- Run by
- Harvard Medical School (HMS and HSDM)
See details and how to joinNCT07814872 - No phaseTaking peopleIncreasing Equity in Lung Cancer Screening
- Where
- Indianapolis
- Age
- 50 years to 80 years
- People
- 144
- Run by
- Indiana University
See details and how to joinNCT06360822 - Phase 2Taking peopleStereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Where
- Boston
- Age
- 18 years and over
- People
- 134
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT04899908 - Phase 1Taking peopleA Phase 1/1b Study of IAM1363 in HER2 Cancers
- Where
- Ann Arbor, Aurora, Austin, Boston, Chicago, Cleveland, Dallas, Detroit, Durham, Fairfax, Grand Rapids, Houston, Kansas City, La Jolla, Lebanon, Los Angeles, Miami, Nashville, New Brunswick, New York, Oklahoma City, Portland, Seattle, St Louis, St. Petersburg, West Valley City
- Age
- 18 years and over
- People
- 383 worldwide
- Run by
- Iambic Therapeutics, Inc
See details and how to joinNCT06253871 - Phase 1/2Taking peopleSafety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
- Where
- Charleston, Dallas, East Providence, Grand Rapids, Huntersville, Louisville, San Antonio
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06750185 - No phaseTaking peopleMolecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care
- Where
- Rochester
- Age
- 18 years and over
- People
- 250
- Run by
- Mayo Clinic
See details and how to joinNCT06482073 - No phaseTaking peopleLeveraging the Emergency Department (LEAD) Study
- Where
- Brick, Edison, Hackensack, Holmdel, Manahawkin, Neptune City, North Bergen, Old Bridge, Perth Amboy, Red Bank
- Age
- 50 years to 80 years
- People
- 100
- Run by
- Hackensack Meridian Health
See details and how to joinNCT06605534 - Phase 2Taking peopleProphylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
- Where
- Boston
- Age
- 18 years and over
- People
- 150
- Run by
- Ayal A. Aizer, MD
See details and how to joinNCT07130786 - Phase 2Taking peopleStereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
- Where
- Boston
- Age
- 18 years and over
- People
- 60
- Run by
- Ayal A. Aizer, MD
See details and how to joinNCT07132190 - Phase 1/2Taking peopleSotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
- Where
- Charlottesville, Cleveland, Columbus, Pittsburgh, Sacramento, Tampa, Wesley Chapel
- Age
- 18 years and over
- People
- 37
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07012031 - Phase 1Taking peopleA Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
- Where
- Austin, Chicago, Fairfax, Grand Rapids, Jacksonville, Lake Success, Nashville, New Haven, New Orleans, New York, Rochester, Scottsdale, St Louis, West Valley City
- Age
- 18 years and over
- People
- 100
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT07361562 - Phase 2Taking peopleLocal Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
- Where
- Houston
- Age
- 18 years and over
- People
- 51
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04892953 - Phase 1Taking peopleOpen-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
- Where
- Aurora, Baltimore, Birmingham, Buffalo, Cleveland, Detroit, Eugene, Fairfax, Houston, Kansas City, La Jolla, Nashville, New Haven, New York, Norwalk, Peoria, Salt Lake City, San Francisco, Santa Monica, Seattle, Tacoma, Waco
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06343402 - Phase 1/2Taking peopleA Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Where
- Buffalo, Fort Worth, Indianapolis, Lake Success, Los Angeles, Sarasota
- Age
- 18 years and over
- People
- 132
- Run by
- InduPro, Inc.
See details and how to joinNCT07602842 - Phase 1Taking peopleA Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Where
- Cleveland, Denver, Fairfax, Houston, Jacksonville, Los Angeles, Morristown, Nashville, New Brunswick, New York, Orlando, Rochester, San Diego, San Francisco
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT04913285 - Phase 1Taking peoplePhase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Where
- Brookline, Chapel Hill, Chicago, Dallas, Fairfax, Fort Worth, Grand Rapids, Houston, Jacksonville, Lone Tree, Milwaukee, Mineola, Nashville, New Brunswick, New York, Norton Shores, Orlando, Phoenix, Port Jefferson Station, Rochester, San Antonio, Seattle, Tyler
- Age
- 18 years and over
- People
- 336
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05245500 - No phaseTaking peopleA Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 26
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05837767 - Phase 1/2Taking peopleStudy of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
- Where
- Houston, Nashville
- Age
- 18 years and over
- People
- 171 worldwide
- Run by
- Pierre Fabre Medicament
See details and how to joinNCT06567015 · EU 2023-510203-21-00 - Phase 1Taking peopleA Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
- Where
- Buffalo, Coral Gables, Detroit, Indianapolis, Jacksonville, Nashville, New York, Peoria, Philadelphia, Pinehurst, Rochester
- Age
- 18 years and over
- People
- 60
- Run by
- Ankyra Therapeutics, Inc
See details and how to joinNCT07027514 - Phase 1Taking peopleFT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Where
- Houston, La Jolla, Los Angeles, Minneapolis, Philadelphia
- Age
- 18 years and over
- People
- 119
- Run by
- Fate Therapeutics
See details and how to joinNCT07216105 - Phase 2Not yet taking people in United StatesCIMAvax-EGF With KRAS G12C Inhibitor for the Treatment of Advanced, KRAS G12C Mutated Non Small Cell Lung Cancer
- Where
- Buffalo
- Age
- 18 years and over
- People
- 29
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT07543172 - Phase 2Taking peoplePhase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Where
- Baltimore, Charlottesville, Chicago, Columbus, La Crosse, Miami, Morristown, New Brunswick, Philadelphia, Pittsburgh, Sayre, The Bronx, Wausau
- Age
- 18 years and over
- People
- 60
- Run by
- PrECOG, LLC.
See details and how to joinNCT07057791 - Early phase 1Not yet taking people in United StatesEvaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
- Where
- Boston, Grand Rapids, New York
- Age
- 18 years and over
- People
- 40
- Run by
- Lumina Pharmaceuticals Inc
See details and how to joinNCT07781852 - No phaseNot yet taking people in United StatesWitness Project Lung
- Where
- Nutley
- Age
- 50 years to 80 years
- People
- 400
- Run by
- Hackensack Meridian Health
See details and how to joinNCT07792824 - Phase 1/2Active, not recruitingA Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- Where
- Boston, Canton, Cerritos, Chicago, Coral Springs, Covington, Dearborn, Fairfax, Honolulu, Houston, Lakeland, Lake Success, Laredo, Las Vegas, Los Angeles, Margate, Miami, Nashville, Newnan, New York, Oklahoma City, Philadelphia, Pittsburgh, Plantation, San Diego, Seattle, Shirley, Silver Spring, St Louis, Tamarac, Washington D.C., Wilson
- Age
- 18 years and over
- People
- 796 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05150691